The allegations of bribery and corruption by the UK company GlaxoSmithKline are a true game changer for the compliance world. This is the first time that the Chinese have enforced their domestic anti-corruption laws against western corporations doing business in China. It makes clear that doing business the 'old fashioned way' in China through bribery and corruption will no longer be tolerated.
Please see full publication below for more information.